Evidence map›Paper›PMID 42081702›Full record

ArticleClinical nuclear medicine2026

Incidental Finding of Gastric Adenocarcinoma on F-18 FES PET/CT in a Patient With Breast Cancer.

Jiaqiong Wang, Russ Kuker

Abstract readCase Reports
In one paragraph

Article in Clinical nuclear medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jiaqiong WangDepartment of Radiology, Division of Nuclear Medicine, Temple University Health System, Fox Chase Cancer Center, Philadelphia.ORCID 0000-0002-7738-4001
Russ KukerDepartment of Radiology, Division of Nuclear Medicine, University of Miami Miller School of Medicine/Jackson Memorial Hospital, Miami, FL.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 68-year-old woman with history of bilateral breast cancer was referred for F-18 fluoroestradiol (F-18 FES) PET/CT to evaluate sclerotic osseous lesions seen on surveillance CT scan. F-18 FES PET/CT showed no focal abnormal increased radiotracer uptake at the bilateral breast, and no suspicious radiotracer-avid lymph nodes or osseous lesions. The same F-18 FES PET/CT showed focal increased radiotracer uptake at the stomach fundus. A follow-up F-18 FDG PET/CT showed no suspicious focal hypermetabolic activity in the stomach. An endoscopic biopsy identified gastric adenocarcinoma.

Indexed as

AdenocarcinomaBreast NeoplasmsEstradiolIncidental FindingsPositron Emission Tomography Computed TomographyStomach NeoplasmsAgedFemaleHumans16-fluoroestradiolEstradiolbreast cancerF-18 FDG PET/CTF-18 FES PET/CTgastric adenocarcinoma

Identifiers

PMID42081702
PMCPMC13132052

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.